期刊文献+

应用GA-BP人工神经网络预测丙戊酸钠血药浓度 被引量:7

Prediction of Serum Sodium Valproate Concentration with GA-BP Artificial Neural Network Model
下载PDF
导出
摘要 目的利用GA—BP人工神经网络技术预测丙戊酸钠血药浓度。方法收集193例应用丙戊酸钠患者的血药浓度监测数据及其性别、身高、体重、肝。肾功能、用药情况等12个相关指标,构建GA—BP人工神经网络模型,预测丙戊酸钠血药浓度。结果30个病例样本的预测结果表明,与实际测定浓度相比,误差值范围为0.61—23.33μg/mL,误差百分率在±5%的为19例,±5%~±10%的为3例,±10%~±15%的为4例,±15%~±20%的为l例,超过±20%的为3例。结论应用CA—BP人工神经网络预测丙戊酸钠血药浓度是可行的,可将其用于丙戊酸钠个体化给药的研究。 Objective To predict serum concentration of sodium valproate in patients by GA-BP artificial neural network. Methods The clinical data of 193 patients were collected, which was used to develop the model. Predictive model on serum concentration of sodium valproate was based on GA-BP artificial neural network. Then, samples were forecasted using the predictive model. Results Serum concentration of sodium valproate from 30 patients demonstrated that the percent prediction errors were within ~5% in 19 cases, between ±5% and ± 10% in 3 cases, between ± 10% and ± 15% in 4 cases, between ± 15% and ±20% in 1 case and greater than 20% in 3 cases. The error range of values was 0.61 - 23.33 μg/mL. Conclusion Prediction of serum concentration of sodium valproate in patients by GA-BP artificial neural network is feasible, and can be used in individualized dosage design.
出处 《今日药学》 CAS 2014年第1期7-10,共4页 Pharmacy Today
基金 2012年广东省医院药学研究基金(编号:2012A13)
关键词 GA-BP人工神经网络 丙戊酸钠 血药浓度预测 GA-BP artificial neural network sodium valproate prediction of serum concentration
  • 相关文献

参考文献8

二级参考文献36

  • 1姜德春,王丽,卢炜.用NONMEM法建立中国癫痫儿童丙戊酸钠的群体药动学/药效学结合模型[J].中国临床药理学与治疗学,2005,10(11):1279-1285. 被引量:9
  • 2于洁,邵宏,聂小燕,郭金凤,周颖,崔一民,史录文.CYP2C19基因多态性对癫痫患者丙戊酸血药浓度的影响[J].中国临床药理学与治疗学,2007,12(6):700-704. 被引量:23
  • 3[4]Naguib R N G,Hamdy F C.A general regwession neural network a-nalysis of prognostic markers in prostate cancer.Neurocomputing,1998;19(1):145-150
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5Tan L, Yu JT, Sun YP, et al. The influence of cytochrome oxidase CYP2A6 ,CYP 2B6 ,and CYP 2C9 polymorphismson the plasma concentrations of valproic acid in epileptic patients [J]. Clin Neurol Neurosurg, 2010, 112 (4) : 320.
  • 6Jiang D, Bai X, Zhang Q, et al. Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability ofvalproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling [ J ]. Eur J Clin Pharmacol, 2009,65(12):1187.
  • 7JANKOVIC S M, MILOVANOVIC J R, JANKOVIC S. Factors influencing valproate pharmacokinetics in children and adults [ J~. Int J Clin Pharmacol Ther, 2010, 48 (11 ) : 767-775.
  • 8CORREA T, RODRIGUEZ I, ROMANO S. Population pharma- cokinetics of valproate in Mexican children with epilepsy [ J ]. Biopharm Drug Dispos , 2008, 29(9): 511-520.
  • 9BRIER M E, ZURADA J M, ARONOFF G R. Neural network predicted peak and trough gentamicin concentrations[ J]. Pharm Res, 1995, 12(3) : 406-412.
  • 10GOREN S, KARAHOCA A, ONAT F Y,et al. Prediction of cy- clospofine A blood levels : an application of the adaptive-network- based fuzzy inference system (ANFIS) in assisting drug therapy [J]. Eur J Clin Pharmacol, 2008, 64(8) : 807-.814.

共引文献28

同被引文献93

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部